Sonic Healthcare Profit Margin 2023-2023 | SKHHY

Current and historical gross margin, operating margin and net profit margin for Sonic Healthcare (SKHHY) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Sonic Healthcare net profit margin as of December 31, 2023 is 0%.
Sonic Healthcare Annual Profit Margins
Sonic Healthcare Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Services $8.215B $5.936B
Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services and their collective patients. Sonic Healthcare Limited is based in Sydney, Australia.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $86.493B 10.73
Cencora (COR) United States $43.979B 16.54
DiDi Global (DIDIY) China $22.358B 0.00
Natera (NTRA) United States $21.439B 0.00
ICON (ICLR) Ireland $17.593B 15.67
Viatris (VTRS) United States $14.801B 4.56
Avantor (AVTR) United States $14.538B 21.80
Revvity (RVTY) United States $13.672B 23.75
BioMerieux (BMXMF) France $12.468B 0.00
CochLear (CHEOY) Australia $12.010B 0.00
Solventum (SOLV) United States $11.499B 0.00
Doximity (DOCS) United States $10.879B 64.03
Medpace Holdings (MEDP) United States $10.651B 30.01
Charles River Laboratories (CRL) United States $9.526B 18.41
HealthEquity (HQY) United States $8.292B 41.60
Bausch + Lomb (BLCO) Canada $6.290B 29.28
Amplifon S.p.A (AMFPF) Italy $5.864B 29.89
Sotera Health (SHC) United States $3.838B 20.53
Organon (OGN) United States $3.794B 3.83
BrightSpring Health Services (BTSG) United States $3.037B 64.59
Surgery Partners (SGRY) United States $2.671B 30.45
Concentras Parent (CON) United States $2.608B 0.00
Ardent Health Partners (ARDT) United States $2.294B 0.00
GeneDx Holdings (WGS) United States $2.126B 0.00
Premier (PINC) United States $2.067B 10.76
Alignment Healthcare (ALHC) United States $2.055B 0.00
PACS (PACS) United States $1.995B 0.00
GoodRx Holdings (GDRX) United States $1.711B 44.90
Ryman Healthcare (RYHTY) New Zealand $1.651B 0.00
Teladoc Health (TDOC) United States $1.594B 0.00
Establishment Labs Holdings (ESTA) $1.246B 0.00
Progyny (PGNY) United States $1.237B 25.05
Embecta (EMBC) United States $1.179B 8.24
Pediatrix Medical (MD) United States $1.177B 11.52
CareDx (CDNA) United States $1.149B 0.00
AMN Healthcare Services Inc (AMN) United States $0.891B 6.03
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.787B 0.00
SBC Medicals (SBC) United States $0.553B 0.00
InnovAge Holding (INNV) United States $0.550B 0.00
Auna S.A (AUNA) Luxembourg $0.509B 0.00
Sonida Senior Living (SNDA) United States $0.444B 0.00
DocGo (DCGO) United States $0.431B 16.23
Enhabit (EHAB) United States $0.385B 33.30
COMPASS Pathways (CMPS) United Kingdom $0.276B 0.00
Sera Prognostics (SERA) United States $0.268B 0.00
LifeMD (LFMD) United States $0.213B 0.00
Biodesix (BDSX) United States $0.212B 0.00
MultiPlan (MPLN) United States $0.198B 0.00
Beauty Health (SKIN) United States $0.185B 0.00
Nutex Health (NUTX) United States $0.173B 0.00
ModivCare (MODV) United States $0.163B 8.83
So-Young (SY) China $0.093B 15.80
Ascend Wellness Holdings (AAWH) United States $0.081B 0.00
NeueHealth (NEUE) United States $0.062B 1.65
IceCure Medical (ICCM) Israel $0.051B 0.00
Singular Genomics Systems (OMIC) United States $0.049B 0.00
OncoCyte (OCX) United States $0.036B 0.00
Pheton Holdings (PTHL) China $0.025B 0.00
Co-Diagnostics (CODX) United States $0.025B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.024B 0.00
Oncology Institute (TOI) United States $0.017B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
KindlyMD (KDLY) United States $0.006B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Aclarion (ACON) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.001B 0.00